Cargando…

Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer

Stereotactic body radiotherapy (SBRT) demonstrates excellent local control in early stage lung cancer, however a quarter of patients develop recurrence or distant metastasis. Transforming growth factor-beta (TGF-β) supports metastasis and treatment resistance, and angiotensin receptor blockade (ARB)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maloney, Lauren T., Latour, Emile, Chen, Yiyi, Rice, Douglas, Grossblatt-Wait, Alison, Nabavizadeh, Nima, Thomas, Charles R., Young, Kristina H., Walker, Joshua M., Holland, John, Grossberg, Aaron J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542943/ https://www.ncbi.nlm.nih.gov/pubmed/36201632 http://dx.doi.org/10.1080/15384047.2022.2126250

Ejemplares similares

Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
por: Al Feghali, Karine A., et al.
Publicado: (2020)

The current role of surgery and SBRT in early stage of small cell lung cancer
por: Farré, Núria, et al.
Publicado: (2021)

Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting
por: Chaurasia, Avinash R, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof
por: Fan, Shaonan, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
por: Mercier, Stéphanie L., et al.
Publicado: (2022)

SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
por: Wegner, Rodney E, et al.
Publicado: (2018)

Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer
por: Shang, Haijiao, et al.
Publicado: (2020)

A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer
por: Wang, Xin, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
por: Gkika, Eleni, et al.
Publicado: (2023)

Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early‐stage prostate cancer
por: Xiang, Hong F., et al.
Publicado: (2017)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT
por: Albano, Denise, et al.
Publicado: (2018)

Applying PET-CT for predicting the efficacy of SBRT to inoperable early-stage lung adenocarcinoma: A Brazilian case-series
por: Moraes, Fabio Y., et al.
Publicado: (2022)

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
por: Singh, Anurag K., et al.
Publicado: (2018)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Primary Lung Cancer in Recipients of Lung Transplant
por: Moore, Assaf, et al.
Publicado: (2020)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
por: Padgett, Kyle R, et al.
Publicado: (2018)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection
por: Song, Andrew J., et al.
Publicado: (2021)

Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
por: Owen, Dawn, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019)

Multiple Primary Lung Cancers: Treatment Outcomes After Stereotactic Body Radiotherapy (SBRT)
por: Choi, Gyujae, et al.
Publicado: (2023)

Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT)
por: Dupic, Guillaume, et al.
Publicado: (2020)

A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
por: Zhang, Ran, et al.
Publicado: (2021)

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
por: Nikitas, John, et al.
Publicado: (2019)

Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Taylor, James M, et al.
Publicado: (2020)

Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020)

Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer
por: Bai, Xue, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer
por: Mayne, Nicholas R., et al.
Publicado: (2020)

Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
por: Vlaskou Badra, Eugenia, et al.
Publicado: (2021)

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer
por: Bae, Bong Kyung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n00rumnveiunj1080lbcq9sb3t